/Companies

Avelas Biosciences

4 known investors

Find your way into Avelas Biosciences

Sign up to see every warm intro you have to Avelas Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Avelas Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.

Investors · 4

Also in the syndicate · 2

WuXi AppTecWuXi PharmaTech Investments

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Avelas Biosciences do?
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Who are Avelas Biosciences's investors?
Avelas Biosciences's investors include Torrey Pines Investment, Alexandria.